Gene Silencing Market Outlook 2025–2029: Emerging Opportunities and Key Drivers

Uncover key drivers, emerging technologies, and competitive movements shaping the gene silencing market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Gene Silencing Market And What Value Is Projected For 2029?

The gene silencing market has seen substantial expansion in recent years. It is anticipated to increase from $5.97 billion in 2024 to $6.69 billion in 2025, achieving a compound annual growth rate (CAGR) of 12.0%. The past growth can be traced to amplified research in genetic therapies, early innovations in RNA interference, a rise in the prevalence of genetic disorders, greater investment in biotechnology, and expanding biopharmaceutical production capacities.

The gene silencing market is anticipated to experience substantial growth in the coming years, with its size forecast to reach $10.74 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.6%. This expansion during the forecast period is primarily driven by widening applications in rare diseases, technological progress in delivery systems, an escalating demand for personalized medicine, favorable government initiatives, and increasing collaborations between pharmaceutical and biotech companies. Significant trends expected in the forecast period include the development of targeted gene therapies, the advent of CRISPR-based silencing techniques, a greater focus on rare and orphan diseases, the introduction of nanoparticle delivery technologies, and the broadening of gene silencing applications into agriculture.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24224&type=smp

What Factors Are Boosting The Gene Silencing Market?

The increasing occurrence of genetic disorders is projected to fuel the expansion of the gene silencing market in the future. Genetic disorders are defined as health conditions resulting from anomalies in an individual’s DNA. Their detection is on the rise due to advancements in diagnostic technologies, greater public awareness, and wider access to genetic testing. This increase in genetic disorders is associated with rising parental age, which heightens the risk of genetic mutations being passed to offspring. Gene silencing provides a promising method for addressing genetic disorders by selectively halting the expression of defective or disease-causing genes. For example, in August 2023, Down Syndrome UK, a UK-based charity, reported that Down syndrome affects an estimated 40,000 people in the UK, with approximately 1 in every 800 babies born with the condition. Thus, the escalating prevalence of genetic disorders is stimulating the growth of the gene silencing market.

What Are The Core Segmentation Criteria In The Gene Silencing Market?

The gene silencing market covered in this report is segmented –

1) By Type: Transcriptional, Post-Transcriptional, Meiotic

2) By Gene Silencing: RNA Interference (RNAi), Antisense Oligonucleotides (ASOs), Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Or Cas9 -Based Gene Silencing, Other Gene Silencings

3) By Application: Neurology, Oncology, Infectious Diseases, Metabolic Diseases, Therapeutics Manufacturing, Other Applications

4) By End-Users: Pharmaceutical And Biotechnology Companies, Research Institutes and Academic Centers, Hospitals, Clinics, Other End-Users

Subsegments:

1) By Transcriptional: DNA Methylation, Histone Modification

2) By Post-Transcriptional: RNA Interference (RNAi), Antisense Oligonucleotides, MicroRNA (miRNA) Mediated Silencing

3) By Meiotic: Meiotic Gene Conversion, Transposable Element Silencing

Which Emerging Trends Are Reshaping The Gene Silencing Market Landscape?

Leading firms within the gene silencing market are concentrating on creating advanced technologies, like small interfering RNA (siRNA), to improve the accuracy and effectiveness of gene therapy. Small interfering RNA (siRNA) is an RNA molecule essential to the RNA interference (RNAi) pathway; it functions by attaching to particular messenger RNA (mRNA) and facilitating its breakdown, thus inhibiting the formation of proteins responsible for diseases. As an illustration, in October 2024, Judo Bio Inc., a US-based biotechnology firm, introduced siRNA, a cutting-edge medication employing small interfering RNA (siRNA) for gene silencing. Its distinctive characteristics encompass patented delivery mechanisms, such as lipid nanoparticles or conjugated ligands, which guarantee effective absorption by particular cells or tissues, along with AI-driven platforms that speed up the process of identifying suitable gene targets.

Which Players Are Shaping The Competitive Landscape Of The Gene SilencingXX Market?

Major companies operating in the gene silencing market are Roche Holding AG, Merck & Co. Inc., AstraZeneca plc, Novartis International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Alnylam Pharmaceuticals Inc., GenScript Biotech Corporation, Oxford BioMedica plc, Ionis Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., New England Biolabs Inc., Quark Pharmaceuticals Inc., Sirion Biotech GmbH, Benitec Biopharma Limited, GeneCopoeia Inc., Revvity Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/gene-silencing-global-market-report

What Regional Trends Are Shaping Growth In The Gene Silencing Market?

North America was the largest region in the gene silencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene silencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24224&type=smp

Browse Through More Reports Similar to the Global Gene Silencing Market 2025, By The Business Research Company

Genes Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Cell And Genes Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

Cell And Gene Therapy Market 2025

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795